SEELOS THERAPEUTICS, INC.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$21.1M

548 transactions

Summary

SEELOS THERAPEUTICS, INC. is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $12.1MSales: $1.2M45 insiders

Date	Insider	Type	Value
2023-11-30	Golembiewski Michael Joseph(Chief Financial Officer)	Buy	$100K
2023-12-01	Mehra Raj(See Remarks)	Buy	$100K
2023-02-28	Golembiewski Michael Joseph(Chief Financial Officer)	A	$8K
2023-08-31	Golembiewski Michael Joseph(Chief Financial Officer)	A	$8K
2024-02-29	Golembiewski Michael Joseph(Chief Financial Officer)	A	$458.7
2024-01-12	Golembiewski Michael Joseph(Chief Financial Officer)	A	$0
2024-01-12	Mehra Raj(See Remarks)	A	$0
2024-01-04	O'Connor Daniel J.	A	$0
2024-01-04	Lian Brian	A	$0
2024-01-04	DALESANDRO MARGARET	A	$0
2024-01-04	Pascoe Richard W	A	$0
2023-12-01	Mehra Raj(See Remarks)	Buy	—
2023-03-30	Golembiewski Michael Joseph(Chief Financial Officer)	A	$0
2023-03-30	Golembiewski Michael Joseph(Chief Financial Officer)	A	$0
2023-03-30	Mehra Raj(See Remarks)	A	$0
2023-03-30	Mehra Raj(See Remarks)	A	$0
2023-01-05	Lian Brian	A	$0
2023-01-05	DALESANDRO MARGARET	A	$0
2023-01-05	O'Connor Daniel J.	A	$0
2023-01-05	Pascoe Richard W	A	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

SEELOS THERAPEUTICS, INC. — Contributions, Lobbying & Contracts | Poliscope